No abstract available
Publication types
-
Editorial
-
Introductory Journal Article
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Carcinoma, Hepatocellular / mortality
-
Carcinoma, Hepatocellular / pathology
-
Carcinoma, Hepatocellular / therapy*
-
Catheter Ablation
-
Chemoembolization, Therapeutic
-
Evidence-Based Medicine
-
Hepatectomy
-
Humans
-
Liver Cirrhosis / complications
-
Liver Cirrhosis / mortality
-
Liver Cirrhosis / pathology
-
Liver Cirrhosis / therapy
-
Liver Neoplasms / mortality
-
Liver Neoplasms / pathology
-
Liver Neoplasms / therapy*
-
Liver Transplantation
-
Neoplasm Staging
-
Niacinamide / analogs & derivatives
-
Niacinamide / therapeutic use
-
Palliative Care
-
Phenylurea Compounds / therapeutic use
-
Sorafenib
Substances
-
Antineoplastic Agents
-
Phenylurea Compounds
-
Niacinamide
-
Sorafenib